Literature DB >> 303528

Developmental abnormalities of the occipital bone in human chondrodystrophies (achondroplasia and thanatophoric dwarfism).

M Marin-Padilla, T M Marin-Padilla.   

Abstract

Specific developmental malformations have been demonstrated in the occipital bone of two chondrodysplastic disorders (achondroplasia and thanatophoric dwarfism). Analysis of these malformations indicates that the occipital bone is primary affected in these disorders. In both cases, the endochondral-derived components of the occipital bone (the basioccipital, the two lateral parts, and the planum nuchale of the squama occipitalis) have failed to grow properly and are smaller and shorter than normal. On the other hand, the planum occipitalis of the squama, which derives from intramembranous ossification, is unaffected. In addition, the nature of these abnormalities indicates that the occipital synchondroses, together with the epiphyseal plates of other bones, are primarily affected in these two chondrodysplasias. The components of the occipital bone formed between the affected synchondroses failed to grow normally. The resulting malformation of the occipital bone is undoubtedly the cause of the shortening of the posterior cerebral fossa and of the considerable narrowing of the foramen magnum often described in these chondrodysplasias. It is postulated that growth disturbances between the affected occipital bone and the unaffected central nervous system results in the inadequacy of the posterior cerebral fossa and the foramen magnum to accommodate the growing brain. Consequently, compression of the brain at the posterior cerebral fossa or the foramen magnum levels could occur and thus lead to neurologic complications such as hydrocephalus and compression of the brain stem. It is suggested that the surgical removal of the fused posterior border of the lateral parts of the occipital bone (partial nuchalectomy) for the purpose of enlarging the narrow foramen magnum may be indicated in those chondrodysplastic children who develop these types of neurologic complications.

Entities:  

Mesh:

Year:  1977        PMID: 303528

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  8 in total

Review 1.  A view of neurospinal dysraphism.

Authors:  C L Berry
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Mortality in achondroplasia.

Authors:  J T Hecht; C A Francomano; W A Horton; J F Annegers
Journal:  Am J Hum Genet       Date:  1987-09       Impact factor: 11.025

3.  A case of achondroplasia with downward displacement of the brain stem.

Authors:  T Nakai; R Asato; Y Miki; F Tanaka; S Matsumoto; J Konishi
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

4.  Quantitative approach to the posterior cranial fossa and craniocervical junction in asymptomatic children with achondroplasia.

Authors:  Rosalinda Calandrelli; Marco Panfili; Gabriella D'Apolito; Giuseppe Zampino; Alessandro Pedicelli; Fabio Pilato; Cesare Colosimo
Journal:  Neuroradiology       Date:  2017-08-17       Impact factor: 2.804

5.  New insights in craniovertebral junction MR changes leading to stenosis in children with achondroplasia.

Authors:  Massimiliano Rossi; Federico Di Rocco; Sara Cabet; Alexandru Szathmari; Carmine Mottolese; Patricia Franco; Laurent Guibaud
Journal:  Childs Nerv Syst       Date:  2022-05-03       Impact factor: 1.532

Review 6.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

7.  Role of the notochord in the development of cephalic structures in normal and anencephalic human fetuses.

Authors:  M Saraga-Babić; M Saraga
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Functional and morphological changes in hypoplasic posterior fossa.

Authors:  Federico Bianchi; Alberto Benato; Paolo Frassanito; Gianpiero Tamburrini; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2021-06-25       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.